Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Edodekin alfa

Drug Profile

Edodekin alfa

Alternative Names: CLMF; human interleukin-12; NKSF; Recombinant human interleukin-12; rhIL-12; rHuIL-12; RO 247472; YM 01C

Latest Information Update: 18 Jul 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Roche; Wistar Institute
  • Developer Bausch Health Companies; Roche
  • Class Adjuvants; Interleukins
  • Mechanism of Action Angiogenesis inhibitors; Cytokine stimulants; Immunostimulants; Interferon gamma stimulants; Interleukin stimulants; Natural killer cell stimulants; T lymphocyte stimulants; Tumour necrosis factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Asthma; Bacterial infections; Cancer; Cutaneous T-cell lymphoma; Graft-versus-host disease; Hepatitis B; Hepatitis C; HIV infections; Kaposi's sarcoma; Leishmaniasis; Lymphoma; Malaria; Malignant melanoma; Non-Hodgkin's lymphoma; Renal cancer

Most Recent Events

  • 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
  • 24 Jun 2018 Biomarkers information updated
  • 04 Sep 2006 Discontinued - Phase-I for Asthma in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top